Search research articles
Contact Us
Filters
Showing results (201-210 of 400) with videos related to
Page
of 40
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
February 19, 2025
Insights from autopsy-initiated pathological studies of the pathogenesis and clinical manifestations of atherosclerosis and ischemic heart disease: Part I. Atherosclerosis
L Maximilian Buja, Michelle M McDonald, Bihong Zhao, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
February 16, 2025
Insights from autopsy-initiated pathological studies of the pathogenesis and clinical manifestations of atherosclerosis and ischemic heart disease: Part II. Ischemic heart disease
L Maximilian Buja, Michelle M McDonald, Bihong Zhao, et al.
Cancer Communications (London, England)
|
July 8, 2024
Boron neutron capture therapy of cancer: where do we stand now?
Rolf F Barth, Gong Wu, Maria da Graca H Vicente, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2008
Giant Cell Arteritis in AJ Americans
J L Gilbert, M D Coe, M H Nam, et al.
Life Sciences
|
August 26, 1999
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528
D Shire, B Calandra, M Bouaboula, et al.
Annals of Diagnostic Pathology
|
April 13, 2000
Laparoscopic postmortem examination: a minimally invasive approach to the autopsy
L J Damore, R F Barth, C D Morrison, et al.
Archives of Pathology
|
January 1, 1971
Excess lipofuscin accumulation in constitutional hepatic dysfunction (Gilbert's syndrome). Light and electron microscopic observations
R F Barth, P M Grimley, P D Berk, et al.
Journal of Medicinal Chemistry
|
September 1, 2006
Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors
Youngjoo Byun, B T S Thirumamagal, Weilian Yang, et al.
Anticancer Research
|
September 1, 1995
In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy
J H Yong, R F Barth, I M Wyzlic, et al.
Cancer Research
|
November 24, 2001
Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy
D R Smith, S Chandra, R F Barth, et al.
Page
of 40
Search research articles
Search
Showing results (201-210 of 400) with videos related to
Sort By:
Page
of 40
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
February 19, 2025
Insights from autopsy-initiated pathological studies of the pathogenesis and clinical manifestations of atherosclerosis and ischemic heart disease: Part I. Atherosclerosis
L Maximilian Buja, Michelle M McDonald, Bihong Zhao, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
February 16, 2025
Insights from autopsy-initiated pathological studies of the pathogenesis and clinical manifestations of atherosclerosis and ischemic heart disease: Part II. Ischemic heart disease
L Maximilian Buja, Michelle M McDonald, Bihong Zhao, et al.
Cancer Communications (London, England)
|
July 8, 2024
Boron neutron capture therapy of cancer: where do we stand now?
Rolf F Barth, Gong Wu, Maria da Graca H Vicente, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2008
Giant Cell Arteritis in AJ Americans
J L Gilbert, M D Coe, M H Nam, et al.
Life Sciences
|
August 26, 1999
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528
D Shire, B Calandra, M Bouaboula, et al.
Annals of Diagnostic Pathology
|
April 13, 2000
Laparoscopic postmortem examination: a minimally invasive approach to the autopsy
L J Damore, R F Barth, C D Morrison, et al.
Archives of Pathology
|
January 1, 1971
Excess lipofuscin accumulation in constitutional hepatic dysfunction (Gilbert's syndrome). Light and electron microscopic observations
R F Barth, P M Grimley, P D Berk, et al.
Journal of Medicinal Chemistry
|
September 1, 2006
Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors
Youngjoo Byun, B T S Thirumamagal, Weilian Yang, et al.
Anticancer Research
|
September 1, 1995
In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy
J H Yong, R F Barth, I M Wyzlic, et al.
Cancer Research
|
November 24, 2001
Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy
D R Smith, S Chandra, R F Barth, et al.
Page
of 40